Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function

Abstract

Macrophage cell therapy improves clinically relevant parameters in experimental chronic liver injury. Paracrine signaling to endogenous cells amplifies the effect. The benefits from this single, defined cell type suggest clinical potential.